Related by context. All words. (Click for frequent words.) 78 oral dihydropyrimidine dehydrogenase DPD 75 folate analogue metabolic 73 solid tumors ZYBRESTAT 73 nilotinib Tasigna ® 73 CYP#A# isoenzyme 72 DNA methyltransferase inhibitors 72 Telik logo TELINTRA 72 Crofelemer budesonide foam 72 humanized therapeutic 72 cladribine Cladribine Tablets 71 pralatrexate injection folate analogue 71 CYP#A# CYP#D# 71 HCV NS5B polymerase 71 NS5B polymerase 71 pharmacogenomic translational research 71 Empatic ™ 71 sulfonylhydrazine class 71 Pruvel TM 71 ABL inhibitor 71 VEGFR2 inhibitor 71 Lenocta TM sodium stibogluconate 71 inflammatory PDE 70 HCV RNA polymerase 70 oral isoform selective HDAC 70 AAG geldanamycin analog 70 oral isotype selective HDAC 70 investigational pan BCR 70 ABL inhibitor completing 70 TRIOLEX HE# APOPTONE HE# 70 Budesonide foam crofelemer 70 XL# anticancer compounds 70 MKC# MKC# PP 69 Mg Usa 69 novel topoisomerase 69 certain protein tyrosine 69 IMiDs ® 69 candidate AP# 69 oral Janus kinase 69 Emergent marketed 69 oral picoplatin 69 recurrent metastatic ovarian cancer 69 MAGE A3 ASCI 69 IMPDH inhibitor 69 CYT# potent vascular disrupting 69 non peptidic protease 69 MSCRAMM ® 69 Xcytrin R 69 monoclonal antibody IgG1 Mab 68 R sorafenib tablets 68 Staphylococcus aureus Immune Globulin 68 cytidine nucleoside analog 68 PI3K/Akt pathway inhibitor 68 kidney urologic 68 INSPIRE Trial Phase III 68 IMiDs R 68 ATRA IV 68 oral prodrug 68 platform HDL Mimetic 68 potent topoisomerase II 68 investigational humanized monoclonal antibody 68 SPL# Gel vaginal microbicide 68 TRANSDUR ® 68 pan histone deacetylase 68 selective inverse agonist 68 sapacitabine CYC# 68 virus HCV protease inhibitor 68 cortisol synthesis 68 treat chronic rhinosinusitis 68 mocetinostat MGCD# 68 auristatin E MMAE 68 GVAX ® 68 metaglidasen 68 non nucleoside HCV 68 mertansine 68 dasatinib Sprycel ® 68 R MSCRAMM 68 POTELLIGENT ® Technology 68 OSI flagship 68 YOUR LOCAL ANIMAL SHELTER 68 HCV NS3 protease 67 Cardium Therapeutics TM 67 Oracea TM 67 influenza BCX# purine nucleoside 67 non nucleoside inhibitor 67 accumulate preferentially 67 targeted alpha folate 67 oral Factor Xa 67 candidate deforolimus 67 MKC# MT 67 HuCAL PLATINUM ® CysDisplay 67 CCR9 antagonist 67 candidates Azedra TM 67 Cariprazine 67 triggers apoptosis programmed 67 brand ciclesonide HFA 67 Aeolus Pharmaceuticals Announces 67 Submits Biologics License Application 67 multi kinase inhibitor 67 4SC AG ISIN DE# 67 memantine HCl 67 Albuferon albinterferon alfa 2b 67 forodesine purine nucleoside phosphorylase 67 coronary stent merged 67 hypoxia selective 67 AN# topical anti 67 pipeline ImmunoGen collaborators 67 Aztreonam lysine 67 Sudhir Agrawal D.Phil 67 Files IND 67 lead molecular radiotherapeutic 67 dimebon latrepirdine 67 delivers fluocinolone acetonide FA 67 commercialize CorMedix drug 67 FOLOTYN folate analogue 67 MGCD# fungal Hos2 HDAC 67 Anthrax Toxin 67 Initiates Enrollment 67 EOquin TM phase 67 recombinant PSMA vaccine 67 malignant mesothelioma Alfacell 67 tranquilizers diazepam 67 adrenergic regulation 67 developing Bicifadine serotonin 66 Combination REOLYSIN R 66 SIX RO ROG 66 vapreotide acetate 66 Civacir TM Hepatitis C 66 markets COLAZAL 66 Veronate R 66 anti amnesic 66 TO AVOID PREGNANCY WHILE 66 Lenocta TM 66 evaluating tivozanib 66 oral luteinizing hormone 66 Initiates Phase II 66 thrombin component 66 Nasdaq MNKD focused 66 Pain Neutralizer holds 66 website http:/www.depomed.com 66 4 PDE4 enzyme 66 Additionally Soligenix 66 TM Aganocide 66 novel VDA molecule 66 HYVISC ® treatment 66 convulsive anti depressant 66 carcinoma mCRC 66 Receives Approvable Letter 66 candidates Azedra 66 Completes Patient Enrollment 66 SIX ROG VX 66 Randomized Double blind 66 Mg Uk 66 selectively inhibit replication 66 NATIONAL ECONOMIC COUNCIL DIRECTOR 66 Provectus Pharmaceuticals specializes 66 clinical trials Archexin 66 sorafenib tablets 66 phase III isavuconazole 66 GRNOPC1 contains 66 LymphoStat B belimumab 66 non porcine pancreatic 66 TOCOSOL Camptothecin 66 Zalypsis 66 novel DACH platinum 66 Braylon Edwards bushy beard 66 THE UNDERLYING FUTURE 66 small molecule Hedgehog 66 R Bortezomib 66 Novolimus 66 Horizant ™ 66 investigational HCV polymerase 66 Tezampanel 66 USHE groundbreaking pocket BLU 66 granted Ortec 66 AKT inhibitor 66 NS5b 66 anti aging glycopeptides 66 plus prednisone prednisolone 66 alpha folate receptor 66 anionic backbone 66 motexafin gadolinium Injection 65 world safest multivalent 65 Merck OSI Pharmaceuticals 65 Inc. www.micromet inc.com 65 DP VPA 65 MKC# 65 particularly SANCTURA XR 65 Meets Primary Endpoint 65 orally administered inhibitor 65 agonistic human 65 diets Nevius 65 By SALLY SPAULDING 65 commercialize apixaban 65 signal detection CTSD 65 next generation URAT1 65 cardiac myosin activator omecamtiv 65 Kuvan sapropterin dihydrochloride 65 investigational pharmacologically unique 65 selective A2A adenosine receptor 65 label Lipofen R 65 Through Glycoscience R 65 targeted anticancer biopharmaceuticals 65 lucinactant 65 BRAF kinase 65 primarily enzymatic reactions 65 product candidate Lpathomab 65 novel proprietary KL4 65 STOP SHOPPING FOR 65 novel orally administered 65 huC# DM4 65 oral dual endothelin 65 Cephalon GlaxoSmithKline Schering Plough 65 Sapacitabine 65 Personalized Immunotherapy 65 Pruvel ™ 65 class mGluR5 inhibitor 65 Strep Staph 65 WAS BUT DEV 65 CYP#A# substrate 65 used DNA alkylating 65 naloxol derivative 65 modified glutathione analog 65 Bayer HealthCare Onyx Pharmaceuticals 65 Curis collaborator Genentech 65 HGS ETR1 mapatumumab 65 FDA Approves Novel 65 ZOLINZA 65 fibrosis IPF 65 CAUTIONARY STATEMENT UNDER 65 read Palintologist 65 Aflibercept 65 Custirsen 65 CDK cyclin dependent 65 BY STEFANIE WHITE 65 Curaxin CBLC# 65 Atripla combines 65 Chevrolet Malibu #.#L I4 65 erlotinib Tarceva R 65 R lenalidomide 65 fusion enhancers 65 Hematide ™ 65 oral proteasome inhibitor 65 R Saizen R 65 hypoxia activated prodrug 65 ThermoDox ® clinical 65 Idenix Novartis 65 CD4 monoclonal antibody 65 PRN FDA Approves 65 ® bortezomib 65 By MOISEKAPENDA BOWER 65 NU# direct 65 personalized cellular immunotherapy 65 Elotuzumab 65 candidate REP# 65 PNP inhibitor 65 optical biosensors 65 Aley Niobium Property 65 DG# compounds targeting 65 Nventa proprietary CoVal 65 adhesion molecule EpCAM expressing 65 ADVANCE ILLUMINATE 65 RANK Ligand inhibitor 65 CYTEC INDUSTRIES 65 development peramivir neuraminidase 65 mecarbil 65 mesylate tablets fluoroquinolone antibiotic 65 pentadentate logo R 65 active AKT inhibitor 65 endosomal release 65 immunomodulatory properties 65 2hours #mins #.#secs M 65 novel histone deacetylase 65 Belimumab 65 oral ghrelin agonist 65 INDIVIDUALLY AND AS 65 defensin mimetic antibiotic 65 dependent kinase inhibitor 65 Miraxion Amarin lead 65 Reports Preclinical Data 65 FOLFOX6 chemotherapy regimen 64 automated radiopharmaceutical distribution 64 Capitalism Humane 64 mild vasodilator 64 delivery polymer matrix 64 NEBIDO VANTAS SUPPRELIN LA 64 commercializing oxidized glutathione 64 sunitinib Sutent ® 64 TIMET Reports 64 cosmetic cosmeceutical products 64 using VIAdel TM 64 Symbioscience WISDOM PANEL 64 undergoing elective percutaneous 64 liposomal formulation 64 Biogen Genentech 64 By JENNIFER KOVACS 64 5 fluorouracil leucovorin 64 Vidaza ® 64 RDEA# potent 64 NicVAX TM 64 anti botulism antibody 64 CysDisplay R 64 By RODNEY WILLIAMS 64 human IgG1 monoclonal 64 Exelixis compounds 64 BCG refractory carcinoma 64 Oral Calcitonin 64 camptothecin CPT 64 Vitrasert R 64 oral ferric iron 64 CEL SCI Phase III 64 By HARVEY SIMPSON 64 By Thomas Gryta 64 synthetic cannabinoid compounds 64 Unigene nasal calcitonin 64 compound INCB# 64 METOZOLV ™ ODT metoclopramide 64 skeletal sarcomere activators 64 polysaccharide polymer 64 PEGylated Fab fragment 64 Anidulafungin 64 Announces Tentative Approval 64 Oral NKTR 64 novel therapeutic antibodies 64 Juicy Couture Alberta Ferretti 64 Sturckow eased 64 Nicotine Conjugate Vaccine 64 Hsp# Inhibitor 64 combines bupropion 64 topical antifungal product 64 leading oral taxane 64 Second Pivotal Phase 64 AAG KOS 64 Darapladib 64 programs visit http:/www.bionovo.com 64 molecular imaging radiopharmaceuticals 64 Suzanne Elsworth 64 peptibody 64 Sodium oxybate 64 5 HT2A inverse 64 CRM# Protein 64 oral antiviral 64 Aztreonam Lysine 64 mTOR kinase 64 Achieves Primary Endpoint 64 Famvir R 64 antiangiogenesis therapies 64 var arrMeta = 64 Rigel R# 64 Pharma Merck Serono 64 KL4 Surfactant 64 oncolytic virus therapies 64 Aciphex R 64 BY DANNY GALLAGHER 64 Arno Therapeutics 64 Biomerix Corporation 64 topically applied SEPA 64 progressive metastatic prostate 64 By JAMAAL ABDUL 64 include VALSTAR TM 64 either acutely decompensated 64 induced mucositis 64 agents Tabun Sarin 64 hormone LHRH antagonist 64 jeanswear outerwear packs 64 BY DAVID CRIGGER 64 developing ACAPODENE 64 sleep aids Restoril 64 BUT THEIR 64 candidate AQ4N 64 topical non steroidal 64 R BorderGuard 64 thymidylate synthase 64 D aspartate NMDA receptor 64 drug pipeline TAFA# 64 By JOE SPENCER 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 KIDS FINANCIAL SKILLS 64 acetonide FA 64 lead Aganocide compound 64 product platforms AZX# 64 highly purified pasteurized 64 Array BioPharma Reports 64 JAK2 Inhibitor 64 NMT Medical Announces 64 included exfoliative dermatitis 64 DepoCyt ® Abelcet ® 64 anticoagulant reversing agent 64 stage antibody MT# 64 Aurora Kinase 64 manufactures minimally invasive 64 unique alkylating agent 64 non nucleoside polymerase 64 Emtriva Viread 64 endoscopic autofluorescence imaging 64 epothilones 64 topical gel formulation 64 Unanimously Recommends Approval 64 PDX pralatrexate 64 CTA# Injection 64 include Healive TM 64 Submits NDA 64 M# rationally 64 vaginal candidiasis 64 Liprotamase 64 Fovea Pharmaceuticals subsidiary 64 secretory phospholipase A2 64 Panzem R 64 novel emulsion formulation 64 silicon carbide SiC gallium 64 TURNING INSIGHTS INTO HOPE 64 IgG1 monoclonal antibody 64 Colaris Colaris AP 64 WHATSOEVER WITH RESPECT TO 64 bevacizumab Avastin R 64 originally Djamal 64 Launches Generic Version 64 Presents Preclinical Data 64 ® ranolazine extended 64 include Alferon N 64 small molecule thrombopoietin 64 generation Hsp# inhibitor 64 FOOD OOH IT 64 generation DACH Platinum 64 Schering Plough Remicade 64 THR beta agonist 64 Genentech sanofi aventis 63 developing KL4 surfactant 63 including cyclosporine methotrexate 63 POGO ™ 63 albiglutide 63 http:/www.urigen.com 63 TO GUARANTEE 63 apoptosis inducer 63 novel orally inhaled 63 oral JAK#/JAK# inhibitor 63 HuCNS SC ® 63 data management Clintrial 63 sadia EAST AND 63 chemical conjugates 63 BY JIM DeROGATIS 63 Archexin 63 Initiates Clinical 63 Receives Orphan Drug Designation 63 By Tina Alvey 63 Bosutinib 63 International SMI SYNN 63 cancer indications bafetinib 63 mGluR5 NAM 63 Sanofi Pasteur ALVAC canary 63 delta opioid receptor 63 Terrorist explosives 63 ENMD # 63 itraconazole Sporanox 63 intravenous belinostat 63 novel antimitotic agent 63 HCl PEPCID ® famotidine 63 TELINTRA R 63 highly selective inhibitor 63 Aloprim TM allopurinol sodium 63 Ovitrelle R Serostim 63 USP Tablets PEPCID 63 Panzem NCD 63 IMA# 63 SUSAN WORLEY Star 63 Suppository Hydrocortisone Acetate Rectal 63 IT DIFFICULT TO 63 CINQUIL 63 syndrome overactive bladder 63 BY GEOFF KOHL 63 LymphoStat B TM 63 Talabostat 63 myelofibrosis polycythemia vera 63 RAS MAPK pathway 63 Xolegel Vusion 63 rALLy clinical trial 63 OMNARIS HFA 63 By DANIE HARRELSON 63 Viagra Soft Cialis Soft 63 By ROB BURGESS 63 utilizes InSite Vision 63 proteasome inhibitor 63 compound CMX# 63 THIS COMMISSION 63 BioFocus DPI Galapagos 63 Romiplostim 63 proprietary BiTE ® 63 AND SCRIPTS ARE AVAILABLE 63 5 lipoxygenase activating 63 CXB# 63 Demonstrates Positive 63 estrogen receptor beta agonist 63 Maribavir 63 Romidepsin 63 ion cleanse 63 Epothilone D 63 spillway diverts water 63 Size LT#/#R-# models 63 Chevrolet TrailBlazer #.#L I6 63 Aurora kinase inhibitor 63 HIV protease inhibitor Lexiva 63 rxRNA 63 intravesical infusion therapy 63 Vitamin D analogue 63 5 HT4 agonist 63 IMiDs 63 * olmesartan medoxomil 63 doxepin hydrochloride 63 Calamos Releases Monthly 63 By Katy Burne 63 Navarrete replaces 63 DAILY LARIAT ONE 63 Presents Positive 63 Myogen periodic 63 Reliable UPS Mgmt 63 Serostim ® 63 Deforolimus 63 protein tyrosine phosphatase 1B 63 trastuzumab Herceptin R 63 By MILENKO MARTINOVICH 63 FOLOTYN ® 63 product BioThrax ® 63 By MIKE McKIBBIN 63 gastrointestinal stromal 63 Aganocide 63 Altera Nebulizer System 63 TKB# 63 Dense smoke billowed 63 infectious diseases autoimmune diseases 63 5 FU leucovorin 63 evaluating T DM1 63 By MIKE SACCONE 63 MTP inhibitors 63 5 HT4 63 CCX# 63 OTCBB URGP specialty 63 include Altastaph TM 63 BAHRAINI CITIZENS 63 demonstrated antitumor activity 63 By RICK KRETZSCHMAR 63 Vertex hepatitis C 63 IAP inhibitor 63 promotes MERREM ® 63 BEMA ® 63 Obatoclax 63 rusalatide acetate 63 anaphylactic reactions bronchospasm 63 overactive bladder AA# 63 direct Factor Xa 63 midstage clinical 63 R roscovitine CDK cyclin 63 Antigen Express website 63 AND ORAL STATEMENTS MADE 63 prescribed proton pump 63 CD#.# DOES NOT ENDORSE 63 muscle paralyzer 63 Pegloticase 63 Terra Incognita Golden 63 Humanized Anti 63 FUSILEV enhances 63 MILEY CYRUS CYRUS 63 2 methoxyestradiol 63 ampules containing HGH 63 oral nucleoside analogue 63 WERE YOU SURPRISED 63 THE COMPANY MAY CARRY 63 plasma kallikrein inhibitor 63 novel chimeric natriuretic 63 Teriflunomide 63 HOW LONG WAS 63 aflibercept VEGF Trap 63 Initiates Clinical Trial 63 alpha 2A adrenergic 63 migraine headaches neuropathic pain 63 please visit www.abraxane.com 63 Fibrin MB 63 By BEVERLY CORBELL 63 Tibotec Therapeutics division 63 By PATTI ARNOLD 63 hyaluronidase enzyme 63 TM G SCENT 63 Aflibercept VEGF Trap 63 banned Darvon Darvocet 63 DURECT proprietary 63 use transdermal sumatriptan 63 gemifloxacin mesylate tablets fluoroquinolone 63 Amigal TM 63 Tesetaxel 63 XP# XP# 63 HepeX B TM 63 Regulatory Disclosure 63 6 sulfatase 63 docetaxel Taxotere R 63 cetuximab Erbitux R 63 Naglazyme R 63 peptidic compound 63 candidate oral AP# 63 targeted radiotherapeutic 63 Ostarine ™ 63 candidate SMaRT Replacement 63 NASH Huntington 63 BY MATT PARROTT 63 www.combinatorx.com 63 REGIONAL THEATER TONY AWARD 63 % #F# #v.jsn 63 R Woodfield Suites 63 Repligen Reports 63 Solzira ™ 63 By STEPHEN WILLIS 63 evaluating picoplatin 63 products MKC# PP 63 telomerase therapeutic 63 addressing idiopathic pulmonary 63 Alfacell proprietary ribonuclease 63 Cetrorelix pamoate 63 takes ethosuximide 63 prostate secretory 63 By JOE LANGSTAFF 63 SLGN appears 63 Lenor ® Iams 63 By BOB KRETSCHMAN 63 Copegus R 63 BY ARTHUR HART 62 BENLYSTA belimumab 62 Zoraxel TM 62 interferon beta 1a infertility 62 Telik Announces 62 investigational protease inhibitor 62 Eraxis 62 PKC# 62 Presents Preclinical 62 Phase 2b Trial 62 investigational monoclonal antibody 62 dihydrochloride Tablets 62 AND TO REOFFER 62 Kinase Inhibitor 62 By CANDIA DAMES 62 Using Dip Pen 62 Medidur ™ FA 62 Phase 2b Clinical Trial 62 BY WILLA J. 62 Investigational Oral 62 Methylnaltrexone 62 PORxin TM platforms 62 Barr Receives Approval 62 methylnaltrexone bromide 62 TRISCUIT Samples 62 Firdapse TM 62 Therapeutic Competitors Companies 62 ALN HPN 62 Novel Oral 62 Dementia Related Psychosis 62 biologic antibody 62 Peptide YY 62 targets HGF FGFR 62 R DepoCyt 62 d l leucovorin 62 ARRY # 62 produces synthetic peptide 62 erlotinib Tarceva ® 62 Epothilones 62 SINGLE AMERICAN SOLDIER 62 candidate CRLX# 62 AFREZZA TM 62 Kosan proprietary 62 Anti Tumor 62 EGFR tyrosine kinase inhibitor 62 Antibody Drug Conjugate 62 Amgen discovers develops 62 azelastine hydrochloride 62 TLR7 agonist 62 refractory chronic lymphocytic 62 commercializing dermatological products 62 introduced NEUGENE 62 By JEN DIMASCIO 62 ADP receptor antagonist 62 ® lenalidomide 62 Statin medicines sold 62 Healthaxis NASDAQ HAXS 62 MEK Inhibitor 62 UVV appears 62 Hypertensive adverse reactions 62 proprietary intranasal insulin 62 THE COMPANY 'S STRATEGIES 62 inhalant addiction 62 ENTIRETY IF AND 62 Pharmos pipeline 62 dihydroergotamine mesylate DHE 62 therapeutic monoclonal antibody 62 MEDAREX 62 Prochymal TM 62 DIRECTORS OF AFRICAN QUEEN 62 ELADUR ™ 62 daily injectable lipoglycopeptide 62 ORAL Solo 62 Cephalon GlaxoSmithKline 62 thalidomide Thalomid 62 Matt Mondok Published 62 Begins Dosing 62 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 62 IMiDs ® compound 62 brivanib 62 Anflu R influenza 62 Panflu TM Sinovac 62 myocardial infarction ventricular fibrillation 62 ClearPoint iLabor network 62 http dol#.net index#.html http [001] 62 George Bekey robotics 62 Captisol ® 62 Salix Pharmaceuticals Announces 62 Golimumab 62 vascular occlusive diseases 62 Matt Kenseth Truex 62 antiplatelet compound 62 FDA APPROVES 62 BofI website 62 Endologix Powerlink System 62 Merck Serono Nycomed 62 TRISCUIT crackers 62 metastatic colorectal 62 By Gene Haschak 62 receptor tyrosine kinase inhibitor 62 tubulin inhibitor 62 By Ted Holteen 62 Peyronie disease Frozen Shoulder 62 doxepin HCl 62 EGFr humanized monoclonal antibody 62 BUPHENYL ® sodium phenylbutyrate 62 FRENCH ROUNDUP 62 inhalation anthrax cutaneous anthrax 62 lupus hepatitis C 62 XL# XL# 62 Phase 1b clinical trials 62 Refractory Hodgkin Lymphoma 62 Levoleucovorin 62 Ceflatonin R 62 CCR5 mAb 62 palonosetron hydrochloride Injection Dacogen 62 alvespimycin 62 Mylan Receives Approval 62 WLK appears 62 Quepasa Corporation headquartered 62 TFChem licenses 62 index#.html http dol#.net index#.html 62 oral immunomodulatory 62 David Pilbeam curator 62 diarrhea fatigue asthenia 62 systemic lupus erythematosus rheumatoid 62 XL# XL# XL# XL# 62 Initiates Phase III 62 Oral Fingolimod 62 Halozyme Therapeutics Reports 62 developing ostarine selective 62 Alvine Pharmaceuticals 62 By Beth Sneller 62 clinical trials Archexin ® 62 Seth Borenstein Pauline Jelinek 62 please visit http:/www.atherogenics.com 62 Phase III Pivotal 62 TransVax ™ 62 By DEBORAH HIRSCH 62 Aldurazyme ® 62 peripherally acting 62 OR ESTIMATE 62 Storage Made Simple 62 Edwards Lifesciences AG 62 ARE CONSIDERED 62 AQD class 62 candidate XP# 62 Jason Rosenhouse received 62 www.cellgenesys.com 62 prednisone prednisolone plus 62 please visit http:/www.vandapharma.com 62 lead heptagonist compound 62 TRACON Pharmaceuticals 62 includes AstraZeneca Accolate 62 B Anflu R 62 Vytorin combines 62 ARE PUTTING 62 black salve corrosive 62 assigned Dyax BLA 62 Omacetaxine 62 HGS ETR2 62 orally inhaled migraine 62 rHuPH# recombinant human 62 trademarks Vitrasert ® 62 NEWS RELEASE THE COMPANY 62 Epratuzumab 62 Initiate Phase III 62 MTP inhibitor 62 ® Cheez 62 SPRYCEL ® 62 reformulates existing FDA 62 markets Gelclair R 62 Oral Mist 62 NAMENDA XR 62 collagen sponge seeded 62 UNCERTAINTIES OR OTHER FACTORS 62 tumor activated prodrug 62 Valproic acid 62 adjuvant GIST 62 Zorbtive TM 62 mesylate tablets approved 62 Europe entitled MINDSET 62 Sciences ABthrax Albuferon 62 NuMimetic TM 62 Rectangular Column 62 ® Insta Cheques 62 bazedoxifene conjugated estrogens 62 docetaxel Taxotere ® 62 MCSP respectively 62 tizanidine hydrochloride short 62 PET FROM 62 Crying Nowak 62 taxane derivative 62 NOT THIS WEBSITE 62 DATA ARE FORWARD 61 dol#.net index#.html http dol#.net [001] 61 small molecule glucokinase 61 Combivir Kivexa 61 Evgeny Novikov Mitsubishi Lancer 61 please visit http:/www.sunesis.com 61 TNF Tumor Necrosis Factor 61 http dol#.net index#.html http [002] 61 Defibtech designs 61 Dean Koontz Bantam FP 61 Perforomist ™ Inhalation Solution 61 acadesine 61 serine protease inhibitor CU# 61 histone deacetylase HDAC 61 Adecatumumab 61 includes iFinix RealTime 61 http:/www.memorypharma.com 61 neuromuscular spasm 61 Perforomist TM formoterol fumarate 61 hepatitis C lupus 61 structure infections ABSSSI 61 ZK EPO 61 Retisert R 61 Completes Enrollment 61 Fusion LTX 61 RON Notch 61 Dapagliflozin 61 OAKLAND ATHLETICS Activated 61 Intermezzo ® zolpidem tartrate 61 BY STEPHANIE A. WILKEN 61 targeting miR 61 platforms GVAX 61 Actress Staci Keanan 61 PROACT Phase 2 61 FDA Okays 61 HIV RDEA# 61 Mike Ackerstein 61 improve impulse conduction 61 Luveris R Ovidrel R 61 oral rivaroxaban 61 beta adrenergic receptor agonists 61 markets XIFAXAN ® 61 targets Galectin receptors 61 Lipid Polymer Micelle LPM 61 Solzira TM 61 BY PETER ABRAHAM 61 CIMZIA ™ 61 MT#/MEDI-# 61 HCV protease inhibitor 61 By Riva Froymovich 61 Cephalon Oncology 61 Silodosin 61 Martin Rauam Mitsubishi Lancer 61 diagnostic molecular imaging 61 products utilizing CPEX 61 Company TAIFUN R 61 % pramoxine HCl 61 trastuzumab DM1 T DM1 61 Receives Fast Track 61 protein kinase inhibitor 61 pegylated interferon peg IFN 61 Study Evaluating 61 RNAi Therapeutic 61 PROCTOCORT R Suppository Hydrocortisone 61 oral transdermal 61 polyneuropathy HIV DSP 61 Novartis Trileptal 61 vinorelbine tartrate 61 Vorinostat 61 Innovation Societal Impact 61 Boo Jarchow Article 61 5 FU cytotoxic 61 generation URAT1 inhibitor 61 sanofi aventis Bayer Schering 61 refractory gout 61 cMET 61 BY WILLIAM ROLLER 61 essential thrombocythemia ET 61 FULL IMPACT 61 Nexavar sorafenib tablets 61 Solution XOPENEX HFA 61 Adenosine Therapeutics 61 markets Testim ® 61 Chrysalin r rusalatide acetate 61 involuntary dyskinetic movements 61 MGCD# MGCD# [001] 61 PDE4 inhibitor 61 Aganocide R 61 Boehringer Ingelheim MedImmune 61 Pazopanib 61 P#X# antagonist 61 Receives Orphan Drug 61 Carolyn Sackariason Aspen 61 Cobalamin TM mediated 61 Mipomersen 61 PPI omeprazole 61 include ClindaReach TM 61 Entereg R 61 receptor inhibiting monoclonal 61 nasal calcitonin product 61 transformed peptic ulcer 61 Meltaways versions 61 Hormone Refractory Prostate Cancer 61 sodium glucose cotransporter 61 Shows Promise Against 61 omecamtiv mecarbil formerly 61 markets HP Acthar 61 By PATRICK BAHR 61 Visit www.BASInc.com 61 Company CryoPatch ® 61 MetroGel 61 developing Zerenex TM 61 related CMV Retinitis 61 BY CHRIS REDFORD 61 toenail onychomycosis 61 eye socket ruptured 61 tartrate Inhalation Aerosol BROVANA 61 potent suppressor 61 Dispersants contain 61 dol#.net index#.html http dol#.net [002] 61 Glufosfamide 61 inhibitor COX 61 Bilive R combined 61 Kosan dependence 61 JAK inhibitor 61 inhalation aerosol 61 targeting CD# 61 Sie lesen Finanznachrichten und 61 ReneSola Ltd Announces 61 IMPACS TM compounds 61 MICRODUR TM 61 Phase #b/#a clinical 61 apricitabine ATC 61 der Autor GmbH verantwortlich 61 OMP #R# 61 Squibb Genentech 61 HGS# 61 inhibitor PPI 61 HE SPOKE 61 C III Sublingual 61 inhaled formulation 61 systemically administered 61 ospemifene 61 SinuNase ™ 61 Tarvacin Anti Cancer 61 l lysine 61 TRIOLEX ™ 61 OKE appears 61 post herpetic 61 triciribine phosphate monohydrate 61 orally dosed 61 ELADUR TM 61 HQK 61 treat chronic sinusitis 61 targeted antifolate 61 vaccines oncolytic virus 61 Salima Mabry son 61 Therapy RecoveryRx TM 61 adecatumumab MT# 61 tramiprosate Alzhemed TM 61 arsenic trioxide injection 61 sorafenib Nexavar 61 MATTERS DISCUSSED IN 61 midstage trials 61 chimeric monoclonal antibody 61 website www.depomedinc.com 61 Henryk Zientek 61 WIRE #/#/# Researched 61 Afatinib 61 palifosfamide Zymafos TM 61 proprietary PEGylation 61 Atridox R Atrisorb 61 treat musculoskeletal metabolic 61 targeted immunotherapies 61 SAR# [002] 61 selective kinase inhibitor 61 Oracea R 61 Essence Ultra LifePak 61 technology underlying Medidur 61 ACTEMRA TM 61 combining voreloxin 61 neuropathic pain metabolic diseases 61 ® EBLY ® MASTERFOODS 61 ODT metoclopramide HCl PEPCID